GORE® EXCLUDER® Iliac Branch Endoprosthesis is First Dedicated System of Its Kind Registered in Australia and New Zealand
FLAGSTAFF, Ariz. (May 13, 2015) – W. L. Gore & Associates (Gore) today announced the GORE® EXCLUDER® Iliac Branch Endoprosthesis, the first complete, fully engineered system (Gore designed iliac branch and internal iliac components) intended for endovascular treatment of common iliac artery aneurysms or aortoiliac aneurysms, has been included on the Australian Register of Therapeutic Goods. The first patient procedures in Australia were successfully completed by vascular surgeons Dr. Steven Dubenec, Head of Department of Vascular Surgery at Royal Prince Alfred Hospital, Sydney, and Dr. Jack Loa, at Macquarie University Hospital, Sydney.
This new device — used in conjunction with GORE® EXCLUDER® AAA Endoprosthesis components to isolate the common iliac artery from systemic blood flow and preserve blood flow in the external iliac and internal iliac arteries — is built on Gore’s proven technology platform and designed using the same durable, expanded polytetrafluoroethylene (ePTFE) graft.
“Based on the design of the GORE® EXCLUDER® Device, this system provides a wide treatment range and long-term durability, which is extremely important for optimal clinical success,” said Dr. Dubenec. “The pre-cannulated branch and bi-femoral delivery elements of the GORE® EXCLUDER® Iliac Branch Endoprosthesis support the ease of use of this device.”
The GORE® EXCLUDER® Iliac Branch Endoprosthesis system provides a treatment range of 6.5-13.5 mm for the internal iliac arteries, and a treatment range of 6.5-25 mm for the external iliac arteries. The delivery profile of the loaded catheter allows the use of a 16 Fr introducer sheath for the iliac branch component, and a 12 Fr flexible, reinforced introducer sheath for the internal iliac component.
“This new, fully engineered system builds off the trusted performance of the GORE® EXCLUDER® AAA Endoprosthesis, providing physicians with a minimally invasive treatment option for iliac repair,” said Ryan Takeuchi, Gore Aortic Business Leader. “We have made great strides in advancing our GORE® EXCLUDER® Device and branch endoprosthesis portfolio and remain committed to making these innovative devices available to more patients across the world.”
The GORE® EXCLUDER® Iliac Branch Endoprosthesis is part of the growing family of GORE® EXCLUDER® Device products that share a mission to effectively treat aortic aneurysms through minimally invasive means, backed by Gore’s highly rated clinical support team and comprehensive educational offerings.
About W. L. Gore & Associates, Inc.
At Gore, we have provided creative therapeutic solutions to complex medical problems for more than 35 years. During that time, more than 35 million innovative Gore Medical Devices have been implanted, saving and improving the quality of lives worldwide. Our extensive family of products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia and soft tissue reconstruction, staple line reinforcement materials, and sutures for use in vascular, cardiac, and general surgery. We are one of a select few companies to appear on all of the U.S. “100 Best Companies to Work For” lists since the rankings debuted in 1984. For more information, visit www.goremedical.com.
Products listed may not be available in all markets. GORE®, EXCLUDER®, and designs are trademarks of W. L. Gore & Associates. AU0996-EN1 APRIL 2015
Media Contact
Chempetitive Group for W. L. Gore & Associates
Rachel Wallace
+1 781 775 3640
Contact by email